"RNA, Messenger" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
| Descriptor ID |
D012333
|
| MeSH Number(s) |
D13.444.735.544
|
| Concept/Terms |
mRNA, Polyadenylated- mRNA, Polyadenylated
- RNA, Messenger, Polyadenylated
- Messenger RNA, Polyadenylated
- Polyadenylated Messenger RNA
- RNA, Polyadenylated Messenger
- Polyadenylated mRNA
- Poly(A)+ mRNA
|
Below are MeSH descriptors whose meaning is more general than "RNA, Messenger".
Below are MeSH descriptors whose meaning is more specific than "RNA, Messenger".
This graph shows the total number of publications written about "RNA, Messenger" by people in this website by year, and whether "RNA, Messenger" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 12 | 41 | 53 |
| 1997 | 5 | 30 | 35 |
| 1998 | 6 | 36 | 42 |
| 1999 | 5 | 41 | 46 |
| 2000 | 6 | 75 | 81 |
| 2001 | 5 | 55 | 60 |
| 2002 | 2 | 79 | 81 |
| 2003 | 2 | 85 | 87 |
| 2004 | 9 | 77 | 86 |
| 2005 | 5 | 82 | 87 |
| 2006 | 8 | 85 | 93 |
| 2007 | 4 | 58 | 62 |
| 2008 | 10 | 72 | 82 |
| 2009 | 6 | 60 | 66 |
| 2010 | 4 | 72 | 76 |
| 2011 | 7 | 55 | 62 |
| 2012 | 6 | 49 | 55 |
| 2013 | 6 | 58 | 64 |
| 2014 | 11 | 45 | 56 |
| 2015 | 13 | 50 | 63 |
| 2016 | 7 | 37 | 44 |
| 2017 | 9 | 42 | 51 |
| 2018 | 6 | 27 | 33 |
| 2019 | 9 | 17 | 26 |
| 2020 | 2 | 25 | 27 |
| 2021 | 2 | 29 | 31 |
| 2022 | 0 | 44 | 44 |
| 2023 | 0 | 35 | 35 |
| 2024 | 3 | 18 | 21 |
| 2025 | 7 | 9 | 16 |
| 2026 | 1 | 9 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "RNA, Messenger" by people in Profiles.
-
Evaluation of a multiantigen mRNA vaccine against EEHV1A in Asian elephants. J Virol. 2026 Aug 18; 100(8):e0038826.
-
First evidence of clinical protection from an EEHV1A mRNA vaccine in naturally infected juvenile elephants. J Virol. 2026 Aug 18; 100(8):e0218625.
-
Coordinated regulation by lncRNAs results in tight lncRNA-target couplings. Cell Genom. 2025 Aug 13; 5(8):100927.
-
Nebulization of an mRNA-encoded monoclonal antibody for passive immunization of foals against Rhodococcus equi. Mol Ther. 2025 Sep 03; 33(9):4175-4192.
-
Harnessing RNA Technology to Advance Therapeutic Vaccine Antigens against Chagas Disease. ACS Appl Mater Interfaces. 2024 Apr 03; 16(13):15832-15846.
-
Tai Chi improves non-motor symptoms of Parkinson's disease: One-year randomized controlled study with the investigation of mechanisms. Parkinsonism Relat Disord. 2024 Mar; 120:105978.
-
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial. J Infect Dis. 2023 12 20; 228(12):1662-1666.
-
RNA-based translation activators for targeted gene upregulation. Nat Commun. 2023 10 26; 14(1):6827.
-
Bi-allelic variants in INTS11 are associated with a complex neurological disorder. Am J Hum Genet. 2023 05 04; 110(5):774-789.
-
Genetic inhibition of nuclear factor of activated T-cell c2 prevents atrial fibrillation in CREM transgenic mice. Cardiovasc Res. 2022 10 21; 118(13):2805-2818.